| Literature DB >> 28856203 |
T P Griffin1, R Casey1, D Wall2, M Bell1, P M O'Shea3.
Abstract
INTRODUCTION: The high diagnostic accuracy of plasma metanephrines (PMets) in the diagnosis of Phaeochromocytoma/Paraganglioma (PPGL) is well established. Considerable controversy exists regarding optimum sampling conditions for PMets. The use of reference intervals that do not compromise diagnostic sensitivity is recommended. However, the optimum rest period prior to sampling has yet to be clearly established. The aim of this study was to evaluate PMets concentrations in paired blood samples collected following 30 and 40 min seated-rest prior to sampling, in patients in whom it was clinically reasonable to suspect that PPGL may be present. DESIGN AND METHODS: A retrospective cross-sectional study design was used. PMets results from paired blood samples collected after 30 and 40 min seated-rest between January 2009 and June 2015 were recorded. Results were interpreted using reference intervals established in subjects seated and supine.Entities:
Keywords: Diagnostic sensitivity; Diagnostic specificity; Phaeochromocytoma; Plasma metanephrine; Plasma normetanephrine
Year: 2016 PMID: 28856203 PMCID: PMC5574516 DOI: 10.1016/j.plabm.2016.05.001
Source DB: PubMed Journal: Pract Lab Med ISSN: 2352-5517
Fig. 1A. Sampling strategy for plasma free metanephrines & B. Recruitment schematic.
Baseline clinical demographics of study subjects.
| 410 | 379 | 11 | 20 | n/a | |
| 51.8 (15.1) | 50.78 (15.6) | 61.36 (10.6) | 57.33 (10.5) | 0.005 | |
| 210 (51.2%) | 197 (52.0%) | 3 (27.3%) | 10 (50%) | 0.042 |
n/a: Not applicable.
Age in years;
participant samples.
Plasma NMN and MN results collected after 30 and 40 min seated rest.
| Median (range) | 439 (40−14,488) | 413 (40−12,068) | 0.142 | |
| Log mean (SD) | 6.12 (0.65) | 6.06 (0.68) | 0.208 | |
| Median (range) | 429 (40–2161) | 401 (40−1938) | 0.122 | |
| Log mean (SD) | 6.05 (0.53) | 5.99 (0.57) | 0.115 | |
| Median (range) | 3365 (1314−14,488) | 4136 (911−12,068) | 0.847 | |
| Log mean (SD) | 8.31 (0.76) | 8.31 (0.74) | 0.994 | |
| Median (range) | 524 (161−1297) | 530 (169−1289) | 0.978 | |
| Log mean (SD) | 6.30 (0.53) | 6.29 (0.56) | 0.970 | |
| Median (range) | 170 (40–25000) | 168 (40–24,641) | 0.999 | |
| Log mean (SD) | 5.12 (0.63) | 5.11 (0.66) | 0.954 | |
| Median (range) | 171 (40–471) | 170 (40–1110) | 0.912 | |
| Log mean (SD) | 5.10 (0.48) | 5.10 (0.51) | 0.941 | |
| Median (range) | 465 (40–25000) | 428 (40−24,641) | 0.922 | |
| Log mean (SD) | 6.67 (2.00) | 6.63 (2.03) | 0.972 | |
| Median (range) | 104 (40–316) | 94.5 (43−239) | 0.507 | |
| Log mean (SD) | 4.64 (0.49) | 4.55 (0.46) | 0.571 | |
*Upper Reference Limit; NMN: 1180 pmol/L; MN: 510 pmol/L.
Fig. 2Schematic of Natural log of plasma metanephrine (MN) and normetanephrine (NMN) for total study group, no PPGL (phaeochromocytoma or paraganglioma), PPGL and post-PPGL groups.
Diagnostic sensitivity and specificity using seated and supine URLs at Time 30 and 40 min.
| NMN | 100% | 90.9% | 94.8% | 95.6% |
| MN | 36.4% | 36.4% | 97.9% | 97.7% |
| NMN and/or MN | 100% | 90.9% | 94.6% | 94.8% |
| NMN | 100% | 100% | 75.9% | 76.2% |
| MN | 72.7% | 54.5% | 90.9% | 90.9% |
| NMN and/or MN | 100% | 100% | 72.3% | 71.5% |
URL: Upper Reference Limit, NMN: Normetanephrine, MN: Metanephrine.
False-positive test results for PMets using seated and supine URLs at time 30 and 40 min.
| 30 | 40 | 30 | 40 | |
| 14 (3.5%) | 12 (3.0%) | 95 (23.8%) | 93 (23.3%) | |
| 0 (0%) | 3 (0.8%) | 27 (6.8%) | 28 (7.0%) | |
| 21 (5.4%) | 20 (5.2%) | 107 (27.7%) | 110 (28.5%) | |
MN: Metanephrine, NMN: Normetanephrine.